Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use
US6884417B2 · kind B2 · utility
0Cited by
1References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 2001 |
| Grant date | Apr 26, 2005 |
| Priority date | — |
| Expiry date | May 15, 2021 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/804
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns a method of treating LBP-mediated LPS-induced myeloid cell activation comprising administering a therapeutically effective amount of an anti-LBP monoclonal antibody molecule. A therapeutic composition comprising anti-LBP antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.